• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Sainsbury’s stock higher on hopes of interest from Morrisons loser

October 4, 2021 by David Barret Leave a Comment

October 4, 2021

LONDON (Reuters) -Shares in British supermarket group Sainsbury’s rose as much as 3.7% on Monday on hopes SoftBank’s Fortress Investment, which lost out in the auction for Morrisons, may turn its attention to an even bigger player in UK grocery.

Sainsbury’s stock was up 4.2 pence at 288.9 pence at 0858 GMT, valuing the business at 6.7 billion pounds ($9.1 billion).

Fortress was defeated in Saturday’s shootout for Morrisons, Britain’s No. 4 supermarket group, bidding 286 pence a share – a penny less than rival Clayton, Dubilier & Rice.

However, managing partner Joshua A Pack signalled Fortress remained interested in UK assets.

“The UK remains a very attractive investment environment from many perspectives, and we will continue to explore opportunities to help strong management teams grow their businesses and create long-term value,” he said in a statement.

A spokesperson for Fortress declined to comment on Sainsbury’s, which trails only market leader Tesco in UK grocery sales.

A Sainsbury’s spokesperson also declined to comment.

Shares in Sainsbury’s are up 28% this year, buoyed by bid speculation.

That started in April when Czech billionaire Daniel Kretinsky raised his stake in Sainsbury’s to just under 10% and has been fuelled by the bid battle for Morrisons and signs CEO Simon Roberts’s “food first” strategy is starting to work.

($1 = 0.7381 pounds)

(Reporting by James Davey, editing by Ed Osmond)

Source Link Sainsbury’s stock higher on hopes of interest from Morrisons loser

David Barret
David Barret

Related posts:

  1. HPE signs multi-billion dollar NSA computing deal
  2. EU’s chief executive warns against ‘pandemic of the unvaccinated’
  3. Ghana’s economy grew by 8.9% in second quarter, president says
  4. U.S. chipmaker Micron forecasts first-quarter revenue below estimates

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • New Nimbus COVID Variant Present In The UK, Infections Could Spread This Summer
  • Scientists Have Finally Measured How Fast Quantum Entanglement Happens
  • Why Earth’s Magnetic Pole Reversals Are So Fascinating
  • World First Artificial Solar Eclipse Created, The “Closest Thing” To HIV Vaccine Gets FDA Approval, And Much More This Week
  • “Remarkable” Pattern Discovered Behind Prime Numbers, Math’s Most Unpredictable Objects
  • People Are Only Just Learning What The World’s Most Expensive Cheese Is Made Of
  • The Physics Behind Iron: Why It’s The Most Stable Element
  • What Is The Reason Some People Keep Waking Up At 3am Every Night?
  • Michigan Bear Finally Free After 2 Years With Plastic Lid Stuck Around Its Neck
  • Pangolins, The World’s Most Trafficked Mammal, May Soon Get Federal Protection In The US
  • Sharks Have No Bones, So How Do They Get So Big?
  • 2025 Is Shaping Up To Be A Whirlwind Year For Tornadoes In The US
  • Unexpected Nova Just Appeared In The Night Sky – And You Can See It With The Naked Eye
  • Watch As Maori Octopus Decides Eating A Ray Is A Good Idea
  • There Is Life Hiding In The Earth’s Deep Biosphere, But Not As You Know It
  • Two Sandhill Cranes Have Adopted A Canada Gosling, And It’s Ridiculously Adorable
  • Hybrid Pythons Are Taking Over The Florida Everglades With “Hybrid Vigor”
  • Mysterious, Powerful Radio Pulse Traced Back To NASA Satellite That’s Been Dead Since 1967
  • This Is The Best (And Worst) Sleep Position
  • Artificial Eclipse, Dancing Dinosaurs, And 50 Years Of “JAWS”
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version